Palogic Value Management L.P. Sells 100,000 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Palogic Value Management L.P. lowered its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 33.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 200,000 shares of the construction company’s stock after selling 100,000 shares during the quarter. Aspen Aerogels comprises approximately 1.4% of Palogic Value Management L.P.’s holdings, making the stock its 20th largest holding. Palogic Value Management L.P. owned 0.28% of Aspen Aerogels worth $3,156,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of ASPN. AIGH Capital Management LLC bought a new stake in Aspen Aerogels in the 3rd quarter valued at $15,067,000. Mesirow Institutional Investment Management Inc. bought a new stake in Aspen Aerogels in the 4th quarter valued at $12,015,000. Worth Venture Partners LLC bought a new stake in Aspen Aerogels in the 3rd quarter valued at $3,684,000. Federated Hermes Inc. increased its holdings in Aspen Aerogels by 53.9% in the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock valued at $18,211,000 after buying an additional 404,042 shares during the period. Finally, Sora Investors LLC increased its holdings in Aspen Aerogels by 212.5% in the 3rd quarter. Sora Investors LLC now owns 250,000 shares of the construction company’s stock valued at $2,150,000 after buying an additional 170,000 shares during the period. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on ASPN shares. Piper Sandler boosted their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a research note on Wednesday, May 29th. Roth Mkm reiterated a “buy” rating and set a $36.00 price target (up previously from $28.00) on shares of Aspen Aerogels in a research report on Wednesday. TheStreet upgraded shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research report on Wednesday, March 6th. B. Riley boosted their price objective on Aspen Aerogels from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. Finally, Canaccord Genuity Group boosted their price objective on Aspen Aerogels from $18.00 to $28.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. One analyst has rated the stock with a sell rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, Aspen Aerogels currently has a consensus rating of “Moderate Buy” and an average price target of $29.71.

Read Our Latest Analysis on Aspen Aerogels

Aspen Aerogels Stock Up 0.8 %

NYSE ASPN traded up $0.23 during trading hours on Thursday, reaching $30.67. 1,114,791 shares of the company’s stock were exchanged, compared to its average volume of 1,135,580. The company’s 50-day moving average is $23.50 and its two-hundred day moving average is $17.61. Aspen Aerogels, Inc. has a one year low of $5.32 and a one year high of $31.74. The company has a debt-to-equity ratio of 0.24, a quick ratio of 3.29 and a current ratio of 4.01. The company has a market capitalization of $2.34 billion, a price-to-earnings ratio of -69.70 and a beta of 2.29.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its quarterly earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.14. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. The firm had revenue of $94.50 million during the quarter, compared to the consensus estimate of $73.04 million. On average, analysts forecast that Aspen Aerogels, Inc. will post 0.08 EPS for the current fiscal year.

Insiders Place Their Bets

In other Aspen Aerogels news, CEO Donald R. Young sold 256,944 shares of the stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total transaction of $7,513,042.56. Following the transaction, the chief executive officer now owns 502,855 shares in the company, valued at approximately $14,703,480.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, SVP Keith L. Schilling sold 20,000 shares of Aspen Aerogels stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $26.84, for a total transaction of $536,800.00. Following the sale, the senior vice president now directly owns 28,792 shares of the company’s stock, valued at $772,777.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Donald R. Young sold 256,944 shares of Aspen Aerogels stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total value of $7,513,042.56. Following the completion of the transaction, the chief executive officer now directly owns 502,855 shares in the company, valued at $14,703,480.20. The disclosure for this sale can be found here. Insiders sold a total of 3,832,103 shares of company stock valued at $91,679,369 in the last quarter. 4.30% of the stock is currently owned by insiders.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

See Also

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.